BRENDA BLICKHAN: Open Payments
NPI 1063000719 · QUINCY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 23 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $542 · 2025 $780
Food & beverage: $680Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $193 |
| AstraZeneca Pharmaceuticals LP | 4 | $189 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Janssen Biotech, Inc. | 1 | $59 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $53 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Genmab U.S., Inc. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Eisai Inc. | 1 | $20 |
Products named: Enhertu, DATROWAY, RYBREVANT, KEYTRUDA, Nubeqa, SCEMBLIX, BLENREP, OPDIVO.
Industry payments across IL — which companies pay providers there.
